Imaflex Financials

IFX Stock  CAD 1.26  0.01  0.80%   
We were able to interpolate thirty-four available reported financial drivers for Imaflex, which can be compared to its competitors. The stock experiences a moderate upward volatility. Check odds of Imaflex to be traded at C$1.386 in 90 days. Key indicators impacting Imaflex's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.220.23
Sufficiently Down
Slightly volatile
Operating Income3.1 M3.4 M
Moderately Down
Slightly volatile
Current Ratio1.241.77
Way Down
Slightly volatile
  
Understanding current and past Imaflex Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Imaflex's financial statements are interrelated, with each one affecting the others. For example, an increase in Imaflex's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Imaflex's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Imaflex. Check Imaflex's Beneish M Score to see the likelihood of Imaflex's management manipulating its earnings.

Imaflex Stock Summary

Imaflex competes with AirIQ, NamSys, Supremex, Atlas Engineered, and Fab Form. Imaflex Inc., together with its subsidiary, develops, manufactures, and sells flexible packaging materials for consumer, industrial, and agriculture markets in Canada, the United States, and internationally. The company was founded in 1994 and is headquartered in Montreal, Canada. IMAFLEX INC operates under Packaging Containers classification in Canada and is traded on TSX Venture Exchange. It employs 252 people.
Foreign Associate
  USA
Specialization
Consumer Cyclical, Packaging & Containers
InstrumentCanada Stock View All
ExchangeTSX Venture Exchange
ISINCA4524352099
Business Address5710 Notre Dame
SectorContainers & Packaging
IndustryMaterials
BenchmarkDow Jones Industrial
Websitewww.imaflex.com
Phone514 935 5710
CurrencyCAD - Canadian Dollar
You should never invest in Imaflex without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Imaflex Stock, because this is throwing your money away. Analyzing the key information contained in Imaflex's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Imaflex Key Financial Ratios

There are many critical financial ratios that Imaflex's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Imaflex reports annually and quarterly.

Imaflex Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets54.1M65.0M72.0M83.5M96.0M100.8M
Other Current Liab3.2M3.3M3.3M2.1M2.5M1.4M
Net Debt6.6M1.1M502.8K10.6M12.2M9.7M
Retained Earnings21.9M30.3M39.4M39.9M45.9M48.2M
Accounts Payable3.9M5.6M3.4M6.4M7.3M5.6M
Inventory11.7M14.9M12.2M13.2M15.1M8.7M
Other Current Assets238.9K204.8K235.6K343.2K394.6K414.4K
Total Liab18.1M19.9M16.8M27.6M31.8M19.7M
Total Current Assets26.6M38.7M32.0M28.4M32.7M20.2M
Short Term Debt2.7M5.3M5.1M5.9M6.8M5.9M
Net Receivables11.5M15.1M12.1M14.1M16.2M10.5M
Cash3.2M8.5M7.5M799.1K919.0K1.5M
Other Liab1.2M1.2M1.4M2.1M2.4M1.5M
Net Tangible Assets28.5M34.4M43.3M52.9M60.9M30.7M
Good Will478.0K476.0K508.5K496.6K571.1K528.9K
Short Long Term Debt1.9M4.5M4.2M4.2M3.8M4.2M
Intangible Assets1.1M1.3M1.7M1.8M2.0M1.2M
Common Stock11.9M12.6M12.6M12.9M14.9M12.9M
Long Term Debt6.4M5.5M3.5M1.7M1.6M1.5M
Net Invested Capital43.4M53.1M61.0M60.1M69.1M52.7M
Net Working Capital16.8M24.4M20.3M14.0M16.1M16.6M
Capital Stock11.9M12.6M12.6M12.9M14.9M13.5M

Imaflex Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense544.9K411.4K449.4K593.9K683.0K610.3K
Total Revenue86.7M107.5M111.5M93.6M107.6M62.7M
Gross Profit16.6M17.4M18.0M10.8M12.4M8.9M
Operating Income9.3M10.4M10.0M3.0M3.4M3.1M
Ebit9.3M10.4M10.0M3.0M3.4M3.1M
Ebitda12.9M14.2M14.1M7.6M8.7M5.4M
Cost Of Revenue70.1M90.1M93.5M82.8M95.3M53.8M
Income Before Tax8.2M9.8M11.0M813.4K935.4K888.6K
Net Income6.3M8.4M9.1M508.8K585.1K555.8K
Income Tax Expense1.9M1.4M1.9M304.6K350.3K332.8K
Tax Provision1.9M1.4M1.9M304.6K350.3K332.8K
Net Interest Income(544.9K)(411.4K)(408.5K)(438.4K)(504.1K)(529.3K)

Imaflex Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash3.2M5.2M(938.1K)(6.7M)(6.1M)(5.8M)
Free Cash Flow10.3M5.6M2.7M(8.1M)(9.4M)(8.9M)
Depreciation3.6M3.8M4.1M4.6M5.3M5.6M
Capital Expenditures1.7M2.5M14.6M13.0M15.0M15.7M
Net Income6.3M8.4M9.1M508.8K585.1K555.8K
End Period Cash Flow3.2M8.5M7.5M799.1K919.0K1.5M
Change To Inventory37.8K(3.3M)3.2M(1.1M)(1.3M)(1.2M)
Other Non Cash Items(27.1K)(986.7K)(2.7M)10.3M11.9M12.4M
Net Borrowings(3.8M)(6.6M)(550.7K)(3.3M)(2.9M)(2.8M)
Change To Netincome1.0M1.9M465.0K(669.2K)(769.6K)(731.1K)
Investments(1.6M)(2.5M)(14.6M)(13.0M)(11.7M)(11.1M)

Imaflex Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Imaflex's current stock value. Our valuation model uses many indicators to compare Imaflex value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Imaflex competition to find correlations between indicators driving Imaflex's intrinsic value. More Info.
Imaflex is rated second overall in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers reporting about  0.68  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Imaflex is roughly  1.47 . At this time, Imaflex's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Imaflex's earnings, one of the primary drivers of an investment's value.

Imaflex Systematic Risk

Imaflex's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Imaflex volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Imaflex correlated with the market. If Beta is less than 0 Imaflex generally moves in the opposite direction as compared to the market. If Imaflex Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Imaflex is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Imaflex is generally in the same direction as the market. If Beta > 1 Imaflex moves generally in the same direction as, but more than the movement of the benchmark.

Imaflex Total Assets Over Time

Today, most investors in Imaflex Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Imaflex's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Imaflex growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.82)

At this time, Imaflex's Price Earnings To Growth Ratio is fairly stable compared to the past year.

Imaflex March 2, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Imaflex help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Imaflex. We use our internally-developed statistical techniques to arrive at the intrinsic value of Imaflex based on widely used predictive technical indicators. In general, we focus on analyzing Imaflex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Imaflex's daily price indicators and compare them against related drivers.

Additional Tools for Imaflex Stock Analysis

When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.